Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 174

1.
2.
3.

Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II).

Byington RP, Furberg CD, Crouse JR 3rd, Espeland MA, Bond MG.

Am J Cardiol. 1995 Sep 28;76(9):54C-59C.

PMID:
7572688
4.

Effects of lowering average of below-average cholesterol levels on the progression of carotid atherosclerosis: results of the LIPID Atherosclerosis Substudy. LIPID Trial Research Group.

MacMahon S, Sharpe N, Gamble G, Hart H, Scott J, Simes J, White H.

Circulation. 1998 May 12;97(18):1784-90. Erratum in: Circulation 1996 Jun 23;97(24):2479.

5.

Pravastatin, lipids, and atherosclerosis in the carotid arteries: design features of a clinical trial with carotid atherosclerosis outcome.

Crouse JR, Byington RP, Bond MG, Espeland MA, Sprinkle JW, McGovern M, Furberg CD.

Control Clin Trials. 1992 Dec;13(6):495-506.

PMID:
1334821
6.

Results of the primary outcome measure and clinical events from the Asymptomatic Carotid Artery Progression Study.

Probstfield JL, Margitic SE, Byington RP, Espeland MA, Furberg CD.

Am J Cardiol. 1995 Sep 28;76(9):47C-53C.

PMID:
7572686
7.

Effect of pravastatin on progression and regression of coronary atherosclerosis and vessel wall changes in carotid and femoral arteries: a report from the Regression Growth Evaluation Statin Study.

de Groot E, Jukema JW, van Boven AJ, Reiber JH, Zwinderman AH, Lie KI, Ackerstaff RA, Bruschke AV.

Am J Cardiol. 1995 Sep 28;76(9):40C-46C.

PMID:
7572685
8.

The ability of statins to protect low density lipoprotein from oxidation in hypercholesterolemic patients.

Thallinger C, Urbauer E, Lackner E, Graselli U, Kostner K, Wolzt M, Joukhadar C.

Int J Clin Pharmacol Ther. 2005 Dec;43(12):551-7.

PMID:
16372516
9.

Increased oxidation resistance of atherogenic plasma lipoproteins at high vitamin E levels in non-vitamin E supplemented men.

Porkkala-Sarataho E, Nyyssönen K, Salonen JT.

Atherosclerosis. 1996 Jul;124(1):83-94.

PMID:
8800496
10.
11.

B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings: a report of the Regression Growth Evaluation Statin Study (REGRESS).

de Groot E, Jukema JW, Montauban van Swijndregt AD, Zwinderman AH, Ackerstaff RG, van der Steen AF, Bom N, Lie KI, Bruschke AV.

J Am Coll Cardiol. 1998 Jun;31(7):1561-7.

12.

Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II)

Crouse JR 3rd, Byington RP, Bond MG, Espeland MA, Craven TE, Sprinkle JW, McGovern ME, Furberg CD.

Am J Cardiol. 1995 Mar 1;75(7):455-9. Erratum in: Am J Cardiol 1995 Apr 15;75(12):862.

PMID:
7863988
13.

High vitamin E plasma levels and low low-density lipoprotein oxidation are associated with the absence of atherosclerosis in octogenarians.

Cherubini A, Zuliani G, Costantini F, Pierdomenico SD, Volpato S, Mezzetti A, Mecocci P, Pezzuto S, Bregnocchi M, Fellin R, Senin U; VASA Study Group.

J Am Geriatr Soc. 2001 May;49(5):651-4.

PMID:
11380761
14.

Comparison of the effect of two HMG CoA reductase inhibitors on LDL susceptibility to oxidation.

Portal VL, Moriguchi EH, Vieira J, Schio S, Mastalir ET, Buffé F, Bortolini EB, Brüch RS, Rodrigues R.

Arq Bras Cardiol. 2003 Feb;80(2):156-61, 150-5. Epub 2003 Feb 25. English, Portuguese.

16.

A randomized, single-blind, placebo-controlled trial of the effects of 200 mg alpha-tocopherol on the oxidation resistance of atherogenic lipoproteins.

Porkkala-Sarataho EK, Nyyssönen MK, Kaikkonen JE, Poulsen HE, Hayn EM, Salonen RM, Salonen JT.

Am J Clin Nutr. 1998 Nov;68(5):1034-41.

PMID:
9808219
17.

Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?

Simes RJ, Marschner IC, Hunt D, Colquhoun D, Sullivan D, Stewart RA, Hague W, Keech A, Thompson P, White H, Shaw J, Tonkin A; LIPID Study Investigators.

Circulation. 2002 Mar 12;105(10):1162-9.

18.

Lipoprotein oxidation and progression of carotid atherosclerosis.

Salonen JT, Nyyssönen K, Salonen R, Porkkala-Sarataho E, Tuomainen TP, Diczfalusy U, Björkhem I.

Circulation. 1997 Feb 18;95(4):840-5.

19.

Effects of probucol and pravastatin on common carotid atherosclerosis in patients with asymptomatic hypercholesterolemia. Fukuoka Atherosclerosis Trial (FAST).

Sawayama Y, Shimizu C, Maeda N, Tatsukawa M, Kinukawa N, Koyanagi S, Kashiwagi S, Hayashi J.

J Am Coll Cardiol. 2002 Feb 20;39(4):610-6.

20.

Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis.

Salonen JT, Nyyssönen K, Salonen R, Lakka HM, Kaikkonen J, Porkkala-Sarataho E, Voutilainen S, Lakka TA, Rissanen T, Leskinen L, Tuomainen TP, Valkonen VP, Ristonmaa U, Poulsen HE.

J Intern Med. 2000 Nov;248(5):377-86.

Items per page

Supplemental Content

Write to the Help Desk